CONTINUE TO SITE
OR WAIT 15 SECS
Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK
Japanese firm Renascience has concluded a joint research agreement on ageing with Prof. Douglas E. Vaugh
GordonMD Global Investments LP, a US-based investment manager focused exclusively on global public and pr
The Ministry of Science and ICT and the Korea Research Institute of Bioscience and Biotechnology have announce
The Australian Government is investing close to $20 million in funding for researchers to support groundbreaki
The Hong Kong Polytechnic University (PolyU) and Peking University Third Hospital (PUTH) have signed a Memoran
BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in the US,
Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart bloo
Global Contract Development and Manufacturing Organizations (CDMOs) BioCina and NovaCina, based in Australia,
South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has
APAC takes Centre stage in AI-Driven Drug Discovery
The Asia-Pacific (APAC) region is rapidly emerging as a leader in AI-driven drug discovery, fuelled by robust research ecosystems and strong industry collaboration. Substantial investments, cutting-edge technologies, and strategic partnerships are optimising drug development efficiency. As Artificial Intelligence (AI) has become more embedded into many facets of everyday life, it has become an indispensable part of the drug discovery landscape. 2024 was the year of reckoning when AI in drug discovery received the highest validation—three researchers who leveraged the neural network AI programme AlphaFold to predict protein structures won the Nobel Prize in Chemistry. The industry is pushing ahead, using tech to make the business of drug development faster, safer, and more economical. Morgan Stanley estimates that AI's use in drug development could lead to 50 more successful treatments over a decade, potentially creating a $50 billion market.
APAC takes centre-stage in AI-driven drug discovery
Accelerating Cancer Treatment with Precision Medicine & NGS
Malaysia Turns Key Med Tourism Hub
“Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly”
ISPOR 2025
ISPOR
info@ispor.org https://www.ispor.org/conferences-education/event/2025/05/13/default-calendar/ispor-2025Montreal
RNAI Therapeutics 2025
SAE Media Group
events@saemediagroup.com https://www.smgconferences.com/pharmaceuticals/uk/conference/rna-therapeuticsLondon
